Table 3.
Clinical indications | FPOS rates |
---|---|
Lymphoma | 60.7% (632/1,042) |
Pituitary gland dysfunction | 60.8% (379/623) |
Chronic headache | 64.0% (429/670) |
Dizziness | 70.9% (1,579/2,227) |
Hypertension | 71.2% (1,300/1,826) |
Sensation loss | 72.0% (542/753) |
Vision changes | 73.8% (807/1,093) |
Coronary artery disease | 74.3% (609/820) |
Dyspnea on exertion | 75.2% (1,473/1,958) |
Lymphadenopathy | 79.1% (1,048/1,325) |